首页 | 本学科首页   官方微博 | 高级检索  
     

参附注射液配合西药治疗慢性再生障碍性贫血对红细胞免疫功能的影响
引用本文:王素云,邓凯,魏影非,杜惠兰,王超,李杰,李燕,郝洪岭. 参附注射液配合西药治疗慢性再生障碍性贫血对红细胞免疫功能的影响[J]. 现代中西医结合杂志, 2007, 16(16): 2190-2191
作者姓名:王素云  邓凯  魏影非  杜惠兰  王超  李杰  李燕  郝洪岭
作者单位:1. 河北省人民医院,河北,石家庄,050051
2. 河北医科大学第二医院,河北,石家庄,050000
3. 河北医科大学中西医结合学院,河北,石家庄,050000
基金项目:河北省中医药管理局科研课题(05134)
摘    要:目的观察参附注射液对慢性再生障碍性贫血(CAA)患者的临床疗效及对红细胞免疫功能的影响。方法将50例CAA患者随机分为参附组(参附注射液配合西药治疗)30例及对照组(单纯西药治疗)20例,观察2组患者治疗效果及红细胞免疫功能的变化。结果治疗前CAA患者C3bRR均显著性降低(P<0.01),治疗后均较治疗前显著升高(P<0.01)。治疗后2组C3bRR水平比较有显著性差异(P<0.05)。结论参附注射液可能通过调节免疫功能发挥作用,从而提高CAA的疗效。

关 键 词:参附注射液  再生障碍性贫血  红细胞免疫
文章编号:1008-8849(2007)16-2190-02
修稿时间:2006-11-20

Effect of Shenfu Injection combined with western medicine on erythrocytes immune function in the treatment for chronic aplastic anemia
WANG Su-yun,DENG Kai,WEI Ying-fei,DU Hui-lan,WANG Chao,LI JiE,LI Yan,HAO Hong-ling. Effect of Shenfu Injection combined with western medicine on erythrocytes immune function in the treatment for chronic aplastic anemia[J]. Modern Journal of Integrated Chinese Traditional and Western Medicine, 2007, 16(16): 2190-2191
Authors:WANG Su-yun  DENG Kai  WEI Ying-fei  DU Hui-lan  WANG Chao  LI JiE  LI Yan  HAO Hong-ling
Affiliation:WANG Su-yun1,DENG Kai2,WEI Ying-fei1,DU Hui-lan3,WANG Chao1,LI JiE1,LI Yan1,HAO Hong-ling1
Abstract:Objective It is to observe the effect of Shenfu Injection(SFI) on clinical efficacy and erythrocytes immune function in patients with chronic aplastic anemia(CAA).Methods 50 patients with CAA were randomly divided into 30 cases of SFI group treated with SFI plus western medicine and 20 cases of control group treated with western medicine alone.The clinical efficacy and erythrocytes immune function before and after treatment were observed.Results Compared with the normal group,the C3bRR levels were significantly lower in the SFI group and control group before treatment(P<0.01).After being treated,the C3bRR levels in the two groups above were significantly higher than that before treatment(P<0.01).There was a significant difference in C3bRR level between the two group after treatment(P<0.05).Conclusion SFI might promote the clinical efficacy through improving the erythrocytes immune function.
Keywords:Shenfu Injection  chronic aplastic anemia  erythrocytes immune function
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号